Brian A. Jonas

10.0k citations
124 papers · 3.6k · 3 hit papers · h-index 26

Impact in

  • Hematology top 0.2%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma Research and Treatments
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 1%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 88
    • Chronic Myeloid Leukemia Treatments 33
    • Multiple Myeloma Research and Treatments 19
    • Histone Deacetylase Inhibitors Research 20
    • Protein Degradation and Inhibitors 15

Brian A. Jonas

117 papers receiving 3.6k citations

Brian A. Jonas's Hit Papers

Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine 2024 · 57 citations
570+2+5Years since publication4008001.2k

Peers

Brian A. Jonas
Comparison fields: 5 of 89
  • Hematology 2.4k
  • Genetics 557
  • Molecular Biology 1.7k
  • Oncology 562
  • Public Health, Environmental and Occupational Health 488
Replace Thomas Prébet with:
Thomas Prébet France
Sören Lehmann Sweden
Felicitas Thol Germany
Hetty E. Carraway United States
Christopher A. Eide United States
Anupriya Agarwal United States
Virginia M. Klimek United States
Emanuela Ottaviani Italy
Ralph Wäsch Germany
Agnieszka Wierzbowska Poland
Brian A. Jonas relative to Thomas Prébet France Thomas Prébet's profile →
Citations per field
00.5×3.1×
Thomas Prébet · 1×
Citations per year

Countries citing papers authored by Brian A. Jonas

Since Specialization
Citations

This map shows the geographic impact of Brian A. Jonas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian A. Jonas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian A. Jonas more than expected).

Fields of papers citing papers by Brian A. Jonas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian A. Jonas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian A. Jonas. The network helps show where Brian A. Jonas may publish in the future.

Co-authors

The 25 scholars most cited alongside Brian A. Jonas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brian A. Jonas Line = papers co-authored together Brian A. Jonas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Hit paper breakdown →
20181210
2
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
Hit paper breakdown →
2018508
3 2019124
4 2020107
5 2021105
6 202280
7 202172
8 200467
9 201962
10
Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine
Hit paper breakdown →
202457
11 200556
12 201553
13 202153
14 200550
15 202250
16 201845
17 202138
18 201738
19 201638
20 202236

About Brian A. Jonas

Brian A. Jonas is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Public Health, Environmental and Occupational Health, having authored 124 papers that have together received 3.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (88 papers), Chronic Myeloid Leukemia Treatments (33 papers), Acute Lymphoblastic Leukemia research (22 papers), Histone Deacetylase Inhibitors Research (20 papers), Multiple Myeloma Research and Treatments (19 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), Protein Degradation and Inhibitors (15 papers) and Chronic Lymphocytic Leukemia Research (15 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (557 citations), Molecular Biology (1.7k citations), Oncology (562 citations) and Public Health, Environmental and Occupational Health (488 citations). Brian A. Jonas has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Daniel A. Pollyea, Jalaja Potluri, Keith W. Pratz, Courtney D. DiNardo, Brenda Chyla, Andrew H. Wei, Anthony Letai, Marina Konopleva, Martha Arellano and Hagop M. Kantarjian. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Biological Chemistry, Cancers and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact